{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:35:39Z","timestamp":1777559739884,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.ejim.2008.12.005","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T08:27:01Z","timestamp":1235291221000},"page":"424-428","source":"Crossref","is-referenced-by-count":23,"title":["Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Alireza","family":"Esteghamati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Khalilzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Mobarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Tahvildari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda Mojazi","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghasem","family":"Solgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Parivar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrouz","family":"Nikbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliakbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2008.12.005_bib1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves' disease","volume":"343","author":"Weetman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2008.12.005_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","article-title":"A molecular perspective of CTLA-4 function","volume":"24","author":"Teft","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ejim.2008.12.005_bib3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1631\/jzus.2006.B0887","article-title":"Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene","volume":"7","author":"Zhang","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ejim.2008.12.005_bib4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/hmg\/8.7.1195","article-title":"The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus","volume":"8","author":"Vaidya","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejim.2008.12.005_bib5","first-page":"2398","article-title":"The development of Graves' disease and the CTLA-4 gene on chromosome 2q33","volume":"84","author":"Heward","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2008.12.005_bib6","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","article-title":"CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease","volume":"165","author":"Kouki","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2008.12.005_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/thy.1997.7.843","article-title":"CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese","volume":"7","author":"Yanagawa","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2008.12.005_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/thy.2000.10.453","article-title":"Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans","volume":"10","author":"Park","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2008.12.005_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2265.2002.01234.x","article-title":"CTLA-4 gene A-G polymorphism and childhood Graves' disease","volume":"56","author":"Yung","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2008.12.005_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08916930500050319","article-title":"Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population","volume":"38","author":"Ban","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2008.12.005_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clim.2005.09.017","article-title":"Genetic analysis and functional evaluation of the C\/T(\u2212318) and A\/G(\u22121661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease","volume":"118","author":"Chistiakov","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejim.2008.12.005_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/thy.2005.15.232","article-title":"CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population","volume":"15","author":"Petrone","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2008.12.005_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/clim.2001.5121","article-title":"CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease","volume":"101","author":"Hadj Kacem","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejim.2008.12.005_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF03343992","article-title":"Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease","volume":"25","author":"Kouki","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejim.2008.12.005_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1480013","article-title":"Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations","volume":"148","author":"Bednarczuk","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2008.12.005_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.humimm.2006.05.003","article-title":"CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis","volume":"67","author":"Han","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ejim.2008.12.005_bib17","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1167\/iovs.07-1433","article-title":"Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children","volume":"49","author":"Chong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejim.2008.12.005_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1365-2265.2003.01778.x","article-title":"CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism","volume":"58","author":"Vaidya","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2008.12.005_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/0891693032000114544","article-title":"Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease","volume":"36","author":"Kalantari","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2008.12.005_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2370.2004.00455.x","article-title":"CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population","volume":"31","author":"Nakkash-Chmaisse","year":"2004","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.ejim.2008.12.005_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(99)01465-8","article-title":"Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy","volume":"354","author":"Vaidya","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2008.12.005_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.gene.6363752","article-title":"CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms","volume":"2","author":"Ligers","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.ejim.2008.12.005_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.gene.6363869","article-title":"A CTLA-4 gene polymorphism at position \u2212318 in the promoter region affects the expression of protein","volume":"3","author":"Wang","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.ejim.2008.12.005_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00439-005-0006-z","article-title":"CTLA4 is differentially associated with autoimmune diseases in the Dutch population","volume":"118","author":"Zhernakova","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.ejim.2008.12.005_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-0039.2004.00312.x","article-title":"Genetic analysis of the CD28\/CTLA4\/ICOS (CELIAC3) region in coeliac disease","volume":"64","author":"Amundsen","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.ejim.2008.12.005_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","article-title":"Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?","volume":"67","author":"Bednarczuk","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2008.12.005_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","article-title":"Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association","volume":"44","author":"Werner","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2008.12.005_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1034\/j.1399-0039.1999.530112.x","article-title":"CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis","volume":"53","author":"Harbo","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.ejim.2008.12.005_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.58.3.193","article-title":"The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus","volume":"58","author":"Heward","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2008.12.005_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/thy.2006.16.237","article-title":"Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans","volume":"16","author":"Cho","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2008.12.005_bib31","first-page":"369","article-title":"CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region","volume":"52","author":"Frydecka","year":"2004","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.ejim.2008.12.005_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000129676","article-title":"Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism","volume":"70","author":"Namo Cury","year":"2008","journal-title":"Horm Res"},{"key":"10.1016\/j.ejim.2008.12.005_bib33","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/jc.2007-0147","article-title":"Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis","volume":"92","author":"Kavvoura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2008.12.005_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1744-313X.2006.00614.x","article-title":"The common \u2212318C\/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients","volume":"33","author":"Han","year":"2006","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.ejim.2008.12.005_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00542.x","article-title":"No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case\u2013control or family-based studies","volume":"49","author":"Heward","year":"1998","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508003415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508003415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T05:39:24Z","timestamp":1558157964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508003415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0953620508003415"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2008.12.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}